Harvey Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Harvey Capital Management's LLY Position: Q2 2026 in Review
Harvey Capital Management reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $87.9K and leaving 6,287 shares worth $7.54M. The position accounts for 1.55% of the portfolio, ranked #17.
Harvey Capital Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Harvey Capital Management held 6,287 shares of Eli Lilly worth $7.54M as of Q2 2026.
- Harvey Capital Management sold 86 Eli Lilly shares in Q2 2026, an estimated $87.9K.
- Eli Lilly made up 1.55% of Harvey Capital Management's portfolio in Q2 2026, its #17 holding.
- Harvey Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Harvey Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.